In this study, we found that higher PD-L1 expression levels were associated with better cost-effectiveness, indicating that patients with advanced ESCC should receive appropriate treatment regimens in accordance with PD-L1 expression levels in clinical management. Here, CD274 is linked to esophageal squamous cell carcinoma.